(Image: Getty/Victor_Tongdee)

Ketamine: The future treatment of severe mental illness?

By Maggie Lynch

In this first part of a two-part investigation, we look at how NDMA receptor antagonists, such as ketamine, could be poised to make a breakthrough in the treatment of depression – an area where the pharma industry has struggled to identify new targets...

Certara expands PBPK simulator availability

Certara expands PBPK simulator availability

By Melissa Fassbender

Certara has developed a new licensing approach, which provides smaller organizations access to its physiologically-based pharmacokinetic (PBPK) modeling and simulation platform.


Follow us


View more


Featured Suppliers

All suppliers